Text size The future of US stocks fell on Wednesday morning, as Wall Street was concerned about continuing tensions between the US and China, as well as continuing fears about the coronavirus and the cost it has affected. to the economy. On the US-China front, tensions escalated after the US …
Read More »Only a few stocks are fueling the rise in the market. Watch out.
As the S&P 500 falls into positive territory again throughout the year, investors need to be mindful of the fact that a handful of stocks appear to be doing much of the heavy lifting. The benchmark market index rose 1.3% in 2020 through Monday’s close, but much of that profit …
Read More »Gilead Sciences will pay $ 300 million for almost half of Tizona, has the option to buy the rest for $ 1.25 billion
Gilead Sciences Inc. GILD, -1.15% announced Tuesday an agreement to purchase a 49.9% stake in private cancer treatment developer Tizona Therapeutics Inc. for $ 300 million. Gilead also received the option to purchase the rest of Tizona for up to an additional $ 1.25 billion, including possible future milestone payments. …
Read More »Gilead Sciences will pay $ 300 million for almost half of Tizona, has the option to buy the rest for $ 1.25 billion
Gilead Sciences Inc. GILD, -1.29% announced Tuesday an agreement to purchase a 49.9% stake in private cancer treatment developer Tizona Therapeutics Inc. for $ 300 million. Gilead also received the option to purchase the rest of Tizona for up to an additional $ 1.25 billion, including possible future milestone payments. …
Read More »Tesla Shares Get Downgrade in JMP: ‘Investors Face Challenges to Get Additional Returns’
JMP Securities analyst Joseph Osha downgraded Tesla Inc.’s TSLA rating, + 9.47% for the market to outperform the market on Tuesday, the day before the company reports second-quarter earnings. “The company’s valuation now slightly exceeds the $ 1,500 price target we recently set, and we believe that any medium-term success …
Read More »